392 related articles for article (PubMed ID: 32283413)
1. Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: An overview of epidemiology, pathogenesis, diagnosis and pharmacological treatment of Kawasaki disease.
Tang B; Lo HH; Lei C; U KI; Hsiao WW; Guo X; Bai J; Wong VK; Law BY
Phytomedicine; 2020 Apr; 70():153208. PubMed ID: 32283413
[TBL] [Abstract][Full Text] [Related]
2. [Association study of a functional SNP rs28493229 of ITPKC gene and Kawasaki disease in a Chinese population].
Peng Q; Chen CH; Wu Q; Li B; Liao J; Luo CD; Hu XP; Zheng Z; He HL; Zhang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Dec; 28(6):644-8. PubMed ID: 22161096
[TBL] [Abstract][Full Text] [Related]
3. A replication study for association of ITPKC and CASP3 two-locus analysis in IVIG unresponsiveness and coronary artery lesion in Kawasaki disease.
Kuo HC; Hsu YW; Wu CM; Chen SH; Hung KS; Chang WP; Yang KD; Hsieh KS; Chen WC; Onouchi Y; Chang WC
PLoS One; 2013; 8(7):e69685. PubMed ID: 23894522
[TBL] [Abstract][Full Text] [Related]
4. A low-frequency IL4R locus variant in Japanese patients with intravenous immunoglobulin therapy-unresponsive Kawasaki disease.
Amano Y; Akazawa Y; Yasuda J; Yoshino K; Kojima K; Kobayashi N; Matsuzaki S; Nagasaki M; Kawai Y; Minegishi N; Ishida N; Motoki N; Hachiya A; Nakazawa Y; Yamamoto M; Koike K; Takeshita T
Pediatr Rheumatol Online J; 2019 Jul; 17(1):34. PubMed ID: 31269967
[TBL] [Abstract][Full Text] [Related]
5. Kawasaki disease: a comprehensive review of treatment options.
Patel RM; Shulman ST
J Clin Pharm Ther; 2015 Dec; 40(6):620-5. PubMed ID: 26547265
[TBL] [Abstract][Full Text] [Related]
6. Single-nucleotide polymorphism rs2290692 in the 3'UTR of ITPKC associated with susceptibility to Kawasaki disease in a Han Chinese population.
Peng Q; Chen C; Zhang Y; He H; Wu Q; Liao J; Li B; Luo C; Hu X; Zheng Z; Yang Y
Pediatr Cardiol; 2012 Oct; 33(7):1046-53. PubMed ID: 22361738
[TBL] [Abstract][Full Text] [Related]
7. Identification of an association between genomic hypomethylation of FCGR2A and susceptibility to Kawasaki disease and intravenous immunoglobulin resistance by DNA methylation array.
Kuo HC; Chang JC; Kuo HC; Yu HR; Wang CL; Lee CP; Huang LT; Yang KD
Arthritis Rheumatol; 2015 Mar; 67(3):828-36. PubMed ID: 25470559
[TBL] [Abstract][Full Text] [Related]
8. Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease.
Zhang RL; Lo HH; Lei C; Ip N; Chen J; Law BY
Curr Opin Pharmacol; 2020 Oct; 54():72-81. PubMed ID: 32956895
[TBL] [Abstract][Full Text] [Related]
9. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H
Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
[TBL] [Abstract][Full Text] [Related]
10. Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.
Chen MR; Kuo HC; Lee YJ; Chi H; Li SC; Lee HC; Yang KD
Front Immunol; 2021; 12():632890. PubMed ID: 33732254
[TBL] [Abstract][Full Text] [Related]
11. Association of Genetic Polymorphisms in Kawasaki Disease with the Response to Intravenous Immunoglobulin Therapy.
Sapountzi E; Fidani L; Giannopoulos A; Galli-Tsinopoulou A
Pediatr Cardiol; 2023 Jan; 44(1):1-12. PubMed ID: 35908117
[TBL] [Abstract][Full Text] [Related]
12. Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol.
Eleftheriou D; Moraes YC; Purvis C; Pursell M; Morillas MM; Kahn R; Mossberg M; Kucera F; Tulloh R; Standing JF; Swallow V; McCormack R; Herberg J; Levin M; Wan M; Klein N; Connon R; Walker AS; Brogan P
Trials; 2023 Jan; 24(1):60. PubMed ID: 36703139
[TBL] [Abstract][Full Text] [Related]
13. Management of Kawasaki disease.
Eleftheriou D; Levin M; Shingadia D; Tulloh R; Klein NJ; Brogan PA
Arch Dis Child; 2014 Jan; 99(1):74-83. PubMed ID: 24162006
[TBL] [Abstract][Full Text] [Related]
14. HMGB1 gene polymorphism is associated with coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
Ahn JG; Bae Y; Shin D; Nam J; Kim KY; Kim DS
Rheumatology (Oxford); 2019 May; 58(5):770-775. PubMed ID: 30535242
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
Miyata K; Kaneko T; Morikawa Y; Sakakibara H; Matsushima T; Misawa M; Takahashi T; Nakazawa M; Tamame T; Tsuchihashi T; Yamashita Y; Obonai T; Chiga M; Hori N; Komiyama O; Yamagishi H; Miura M;
Lancet Child Adolesc Health; 2018 Dec; 2(12):855-862. PubMed ID: 30337183
[TBL] [Abstract][Full Text] [Related]
16. ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease.
Onouchi Y; Suzuki Y; Suzuki H; Terai M; Yasukawa K; Hamada H; Suenaga T; Honda T; Honda A; Kobayashi H; Takeuchi T; Yoshikawa N; Sato J; Shibuta S; Miyawaki M; Oishi K; Yamaga H; Aoyagi N; Iwahashi S; Miyashita R; Murata Y; Ebata R; Higashi K; Ozaki K; Sasago K; Tanaka T; Hata A
Pharmacogenomics J; 2013 Feb; 13(1):52-9. PubMed ID: 21987091
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous development of Kawasaki disease following acute human adenovirus infection in monozygotic twins: A case report.
Fukuda S; Ito S; Fujiwara M; Abe J; Hanaoka N; Fujimoto T; Katsumori H
Pediatr Rheumatol Online J; 2017 May; 15(1):39. PubMed ID: 28511718
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin, pharmacogenomics, and Kawasaki disease.
Kuo HC; Hsu YW; Wu MS; Chien SC; Liu SF; Chang WC
J Microbiol Immunol Infect; 2016 Feb; 49(1):1-7. PubMed ID: 25556045
[TBL] [Abstract][Full Text] [Related]
19. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
Li W; He X; Zhang L; Wang Z; Wang Y; Lin H; Yuan J; Xie X; Qin Y; Huang P
Cardiovasc Ther; 2021; 2021():6660407. PubMed ID: 34239607
[TBL] [Abstract][Full Text] [Related]
20. [Association of CASP3 gene single nucleotide polymorphisms with Kawasaki disease in Chinese children patients].
Peng Q; Chen CH; Wu Q; Li B; Liao J; Luo CD; Hu XP; Zheng Z; Deng Y; Zhang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Apr; 30(2):180-4. PubMed ID: 23568731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
